113 related articles for article (PubMed ID: 9712470)
21. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Slawson MH; Johnson-Davis KL
Methods Mol Biol; 2016; 1383():11-9. PubMed ID: 26660169
[TBL] [Abstract][Full Text] [Related]
22. High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection.
Matthews CZ; Woolf EJ; Lin L; Fang W; Hsieh J; Ha S; Simpson R; Matuszewski BK
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(2):237-46. PubMed ID: 11236079
[TBL] [Abstract][Full Text] [Related]
23. Sensitive method for determination of nicorandil in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Tanikawa M; Uzu M; Ohsawa Y; Fukushima M
J Chromatogr; 1993 Jul; 617(1):163-7. PubMed ID: 8376532
[TBL] [Abstract][Full Text] [Related]
24. Comparison of fluorescence polarisation immunoassay (FPIA) and high performance liquid chromatography (HPLC) methods for the measurement of flecainide in human plasma.
Hoppe U; Krüdewagen B; Stein H; Hertrampf R; Gundert-Remy U
Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):142-7. PubMed ID: 8468112
[TBL] [Abstract][Full Text] [Related]
25. A simple high-performance liquid chromatographic method for the routine measurement of flecainide in plasma.
Grgurinovich N
J Anal Toxicol; 1988; 12(1):38-41. PubMed ID: 3127637
[TBL] [Abstract][Full Text] [Related]
26. High-performance liquid chromatographic assay of flecainide and its enantiomers in serum.
Lie-A-Huen L; Stuurman RM; Ijdenberg FN; Kingma JH; Meijer DK
Ther Drug Monit; 1989 Nov; 11(6):708-11. PubMed ID: 2512696
[TBL] [Abstract][Full Text] [Related]
27. Fluorometric liquid chromatographic assay of the antiarrhythmic agent flecainide in blood plasma.
De Jong JW; Hegge JA; Harmsen E; De Tombe PP
J Chromatogr; 1982 May; 229(2):498-502. PubMed ID: 7096488
[No Abstract] [Full Text] [Related]
28. Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
Conard GJ; Carlson GL; Frost JW; Ober RE; Leon AS; Hunninghake DB
Clin Ther; 1984; 6(5):643-52. PubMed ID: 6478470
[TBL] [Abstract][Full Text] [Related]
29. Concurrent measurement of flecainide acetate and propranolol by normal-phase high-performance liquid chromatography.
Rognerud CL; Ou CN
Clin Chem; 1989 May; 35(5):857-60. PubMed ID: 2498017
[TBL] [Abstract][Full Text] [Related]
30. [Determination of flecainide concentration in blood plasma by HPLC and pharmacokinetic parameters in volunteers].
Li XY; He JB; Tan WP; Yu ST; Huang W; Sun JP; Yu CH; Qian F
Yao Xue Xue Bao; 1989; 24(6):452-7. PubMed ID: 2514579
[TBL] [Abstract][Full Text] [Related]
31. High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum.
Bhamra RK; Flanagan RJ; Holt DW
J Chromatogr; 1984 May; 307(2):439-44. PubMed ID: 6736191
[No Abstract] [Full Text] [Related]
32. A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection.
Glare PA; Walsh TD; Pippenger CE
Ther Drug Monit; 1991 May; 13(3):226-32. PubMed ID: 1926276
[TBL] [Abstract][Full Text] [Related]
33. Measurement of flecainide acetate in human plasma by an extraction spectrophotofluorometric method.
Chang SF; Miller AM; Jernberg MJ; Ober RE; Conard GJ
Arzneimittelforschung; 1983; 33(2):251-3. PubMed ID: 6682665
[TBL] [Abstract][Full Text] [Related]
34. Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring.
Katori K; Homma M; Kuga K; Yamaguchi I; Sugibayashi K; Kohda Y
J Pharm Biomed Anal; 2003 Jun; 32(2):375-80. PubMed ID: 12763549
[TBL] [Abstract][Full Text] [Related]
35. Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatography.
Beal JL; Tett SE
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):409-15. PubMed ID: 9792527
[TBL] [Abstract][Full Text] [Related]
36. Analysis of flecainide and two metabolites in biological specimens by HPLC: application to a fatal intoxication.
Benijts T; Borrey D; Lambert WE; De Letter EA; Piette MH; Van Peteghem C; De Leenheer AP
J Anal Toxicol; 2003; 27(1):47-52. PubMed ID: 12587684
[TBL] [Abstract][Full Text] [Related]
37. Application of the Empore solid-phase extraction membrane to the isolation of drugs from blood: II. Mexiletine and flecainide.
Lensmeyer GL; Wiebe DA; Doran TC
Ther Drug Monit; 1992 Oct; 14(5):408-15. PubMed ID: 1448850
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection.
Johnson JD; Carlson GL; Fox JM; Miller AM; Chang SF; Conrad GJ
J Pharm Sci; 1984 Oct; 73(10):1469-71. PubMed ID: 6502499
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic drug monitoring of flecainide using high-performance liquid chromatography and comparison with fluorescence polarisation immunoassay.
Woollard GA
J Chromatogr; 1989 Feb; 487(2):409-19. PubMed ID: 2498375
[TBL] [Abstract][Full Text] [Related]
40. Small blood volumes from children for quantitative sotalol determination using high-performance liquid chromatography.
Läer S; Wauer I; Scholz H
J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):421-5. PubMed ID: 11334359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
